|
1
|
Wisdom teeth
|
March 2000
|
Partly recommended
|
|
2
|
Hip replacement
|
April 2000
|
Partly recommended
|
|
3
|
Taxanes for ovarian cancer
|
May 2000
|
Partly recommended
|
|
4
|
Coronary artery stents
|
May 2000
|
Partly recommended
|
|
5
|
Liquid-based cytology—cervical screening
|
June 2000
|
Not recommended
|
|
6
|
Taxanes for breast cancer
|
June 2000
|
Partly recommended
|
|
7
|
Proton pump inhibitors
|
July 2000
|
Partly recommended
|
|
8
|
Hearing aids
|
July 2000
|
Partly recommended
|
|
9
|
Rosiglitazone for type 2 diabetes
|
August 2000
|
Partly recommended
|
|
10
|
Inhaler systems for under 5s
|
August 2000
|
Recommended
|
|
11
|
Implantable cardioverter defibrillators
|
September 2000
|
Partly recommended
|
|
12
|
Glycoprotein llb/llla inhibitors
|
September 2000
|
Recommended
|
|
13
|
Methylphenidate for Attention deficit hyperactivity disorder
|
October 2000
|
Recommended
|
|
14
|
Ribavirin and interferon alpha for hepatitis C
|
October 2000
|
Partly recommended
|
|
15
|
Zanamivir for influenza
|
November 2000
|
Partly recommended
|
|
16
|
Autologous cartilage transplantation in knee joints
|
December 2000
|
Not recommended
|
|
17
|
Laparoscopic surgery for colorectal cancer
|
January 2001
|
Not recommended
|
|
18
|
Laparoscopic surgery for inguinal hernia
|
December 2000
|
Partly recommended
|
|
19
|
Donepezil, Rivastigmine and Galantamine for Alzheimer’s disease
|
January 2001
|
Partly recommended
|
|
20
|
Riluzole for motor neurone disease
|
January 2001
|
Recommended
|
|
21
|
Pioglitazone for type 2 diabetes
|
March 2001
|
Partly recommended
|
|
22
|
Orlistat for obesity
|
March 2001
|
Partly recommended
|
|
23
|
Temozolomide for brain cancer
|
April 2001
|
Partly recommended
|
19 Nov 2008 : Column 523W
19 Nov 2008 : Column 524W
|
24
|
Difficult to heal surgical wounds
|
April 2001
|
Recommended
|
|
25
|
Gemcitabine for pancreatic cancer
|
May 2001
|
Partly recommended
|
|
26
|
Non-small cell lung cancer
|
June 2001
|
Recommended
|
|
27
|
Cox II for osteoarthritis and rheumatoid arthritis
|
July 2001
|
Partly recommended
|
|
28
|
Topetecan for advanced ovarian cancer
|
August 2001
|
Partly recommended
|
|
29
|
Fludarabine for B-cell chronic lymphocytic leukaemia
|
September 2001
|
Recommended
|
|
30
|
Taxanes for breast cancer—review
|
September 2001
|
Partly recommended
|
|
31
|
Sibutramine for obesity in adults
|
October 2001
|
Recommended
|
|
32
|
Beta interferon and glatiramer
|
January 2002
|
Not recommended
|
|
33
|
Colorectal cancer
|
March 2002
|
Partly recommended
|
|
34
|
Tratuzumab breast cancer
|
March 2002
|
Partly recommended
|
|
35
|
Enteracept juvenile arthritis
|
March 2002
|
Partly recommended
|
|
36
|
Enteracept and infliximab rheumatoid arthritis
|
March 2002
|
Partly recommended
|
|
37
|
Rituximab lymphoma
|
March 2002
|
Partly recommended
|
|
38
|
Inhalers 5-15
|
March 2002
|
Recommended
|
|
39
|
Zyban and nicotine replacement therapy
|
March 2002
|
Recommended
|
|
40
|
Infliximab for Crohn’s disease
|
May 2002
|
Partly recommended
|
|
41
|
Routine anti-D rhesus negative women
|
May 2002
|
Recommended
|
|
42
|
Human growth hormone for children
|
May 2002
|
Recommended
|
|
43
|
Atypical antipsychotics
|
June 2002
|
Recommended
|
|
44
|
Metal on metal
|
June 2002
|
Partly recommended
|
|
45
|
Pegylated liposomal doxorubicin hydrochloride (Caelyx) for ovarian cancer
|
July 2002
|
Partly recommended
|
|
46
|
Surgery for morbid obesity
|
July 2002
|
Partly recommended
|
|
47
|
Glycoproteins—review
|
September 2002
|
Recommended
|
|
48
|
Home vs hospital haemodialysis
|
September 2002
|
Partly recommended
|
|
49
|
Ultrasonic locating devices for pacing central venous lines
|
September 2002
|
Recommended
|
|
50
|
Imatinib for chronic myeloid leukaemia (CML)
|
October 2002
|
Recommended
|
|
51
|
Computerised cognitive behavioural therapy
|
October 2002
|
Not recommended
|
|
52
|
Thrombolysis
|
October 2002
|
Recommended
|
|
53
|
Long acting insulin analogues (glargine)
|
December 2002
|
Partly recommended
|
|
54
|
Vinorelbine for breast cancer
|
December 2002
|
Partly recommended
|
|
55
|
Paclitaxel for ovarian cancer
|
January 2003
|
Recommended
|
|
56
|
Tension free vaginal tape
|
February 2003
|
Recommended
|
|
57
|
Subcutaneous insulin infusion (insulin pumps)
|
February 2003
|
Partly recommended
|
|
58
|
Zanamivir, oseltamivir and amantidine for the treatment of flu
|
February 2003
|
Partly recommended
|
|
59
|
Electroconvulsive therapy (ECT)
|
April 2003
|
Partly recommended
|
|
60
|
Patient education models diabetes
|
April 2003
|
Recommended
|
|
61
|
Capecitabine and tegafur with uracil for metastatic colorectal cancer
|
May 2003
|
Recommended
|
|
62
|
Capecitabine for locally advance breast cancer
|
May 2003
|
Recommended
|
|
63
|
Glitazones for type 2 diabetes—review
|
August 2003
|
Partly recommended
|
|
64
|
Human growth hormone in adults
|
August 2003
|
Partly recommended
|
|
65
|
Rituximab for aggressive non Hodgkin’s lymphoma
|
September 2003
|
Partly recommended
|
|
66
|
Olanzapine and valporate semisodium for bipolar 1 disorder
|
September 2003
|
Recommended
|
|
67
|
Oseltamivir and amantidine for prophylaxis of flu
|
September 2003
|
Partly recommended
|
|
68
|
Photodynamic therapy (PDT) for macular degeneration
|
September 2003
|
Partly recommended
|
|
69
|
Use of liquid-based cytology for cervical screening
|
October 2003
|
Recommended
|
|
70
|
Use of imatanib for chronic myeloid leukaemia
|
October 2003
|
Partly recommended
|
|
71
|
Use of coronary artery stents
|
October 2003
|
Partly recommended
|
|
72
|
Rheumatoid arthritis—anakinra
|
November 2003
|
Not recommended
|
|
73
|
Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction
|
November 2003
|
Partly recommended
|
|
74
|
Pre-hospital initiation of fluid replacement therapy in trauma
|
January 2004
|
Partly recommended
|
|
75
|
Hepatitis C—pegylated interferons, ribavarin and alfa interferon
|
January 2004
|
Partly recommended
|
|
76
|
Newer drugs for epilepsy in adults
|
March 2004
|
Partly recommended
|
|
77
|
Newer hypnotic drugs for insomnia
|
April 2004
|
Partly recommended
|
|
78
|
Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding
|
April 2004
|
Partly recommended
|
|
79
|
Newer drugs for epilepsy in children
|
April 2004
|
Partly recommended
|
|
80
|
Acute coronary syndromes—clopidogrel
|
July 2004
|
Recommended
|
|
81
|
Atopic dermatitis (eczema)—topical steroids
|
August 2004
|
Partly recommended
|
|
82
|
Atopic dermatitis (eczema)—pimecrolimus and tacrolimus
|
August 2004
|
Partly recommended
|
|
83
|
Hernia—laparoscopic surgery—review
|
September 2004
|
Partly recommended
|
|
84
|
Sepsis (severe)—drotrecogin
|
September 2004
|
Recommended
|
|
85
|
Renal transplantation—immunosuppressive regimens (adults)
|
September 2004
|
Partly recommended
|
|
86
|
Gastro-intestinal stromal tumours (GIST)—imatinib
|
October 2004
|
Partly recommended
|
19 Nov 2008 : Column 525W
19 Nov 2008 : Column 526W
|
87
|
Secondary osteoporosis
|
January 2005
|
Partly recommended
|
|
88
|
Dual-chamber pacemakers for the treatment of symptomatic bradycardia
|
February 2005
|
Partly recommended
|
|
89
|
Cartilage injury—autologous chondrocyte implantation (ACI)—review
|
May 2005
|
Not recommended
|
|
90
|
Vascular disease—clopidogrel and dipyridamole
|
May 2005
|
Partly recommended
|
|
91
|
Ovarian cancer (advanced)—paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan—review
|
May 2005
|
Partly recommended
|
|
92
|
Tooth decay—Healozone
|
July 2005
|
Not recommended
|
|
93
|
Colorectal cancer (advanced)—irinotecan, oxaliplatin and raltitrexed—review
|
August 2005
|
Partly recommended
|
|
94
|
Cardiovascular disease—statins
|
January 2006
|
Partly recommended
|
|
95
|
Arrhythmia—implantable cardioverter defibrillators (ICDs)—review
|
January 2006
|
Partly recommended
|
|
96
|
Hepatitis B (chronic)—adefovir dipivoxil and pegylated interferon alpha-2a
|
February 2006
|
Partly recommended
|
|
97
|
Depression and anxiety—computerised cognitive behavioural therapy (CCBT)
|
February 2006
|
Partly recommended
|
|
98
|
Attention deficit hyperactivity disorder (ADHD)—methylphenidate, atomoxetine and dexamfetamine—review
|
March 2006
|
Partly recommended
|
|
99
|
Immunosuppressive therapy for renal transplantation in children and adolescents
|
April 2006
|
Partly recommended
|
|
100
|
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes’ C) colon cancer
|
April 2006
|
Recommended
|
|
101
|
Docetaxel for hormone refractory prostate cancer
|
June 2006
|
Recommended
|
|
102
|
Parent-training/education programmes in the management of children with conduct disorders
|
July 2006
|
Recommended
|
|
103
|
Etanercept and efalizumab for psoriasis
|
July 2006
|
Partly recommended
|
|
104
|
Etanercept and infliximab for psoriatic arthritis
|
July 2006
|
Partly recommended
|
|
105
|
Laparoscopic surgery for colorectal cancer
|
August 2006
|
Recommended
|
|
106
|
Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
|
August 2006
|
Recommended
|
|
107
|
Trastuzumab for the adjuvant treatment of early-stage HER2-positive breast cancer
|
August 2006
|
Partly recommended
|
|
108
|
Breast cancer (early)—paclitaxel
|
September 2006
|
Not recommended
|
|
109
|
Breast cancer (early)—docetaxel
|
September 2006
|
Recommended
|
|
110
|
Follicular lymphoma—rituximab
|
September 2006
|
Recommended
|
|
111
|
Alzheimer's—donepezil, galantamine, rivastigmine (review) and memantine
|
November 2006
|
Partly recommended
|
|
112
|
Breast cancer (early)—hormonal treatments
|
November 2006
|
Recommended
|
|
113
|
Diabetes (types 1 and 2)—inhaled insulin
|
December 2006
|
Partly recommended
|
|
114
|
Drug misuse—methadone and buprenorphine
|
January 2007
|
Recommended
|
|
115
|
Drug misuse—naltrexone
|
January 2007
|
Partly recommended
|
|
116
|
Breast cancer—gemcitabine
|
January 2007
|
Partly recommended
|
|
117
|
Hyperparathyroidism—cinacalcet
|
January 2007
|
Partly recommended
|
|
118
|
Colorectal cancer (metastatic)—bevacizumab and cetuximab
|
January 2007
|
Not recommended
|
|
119
|
Leukaemia (lymphocytic)—fludarabine
|
February 2007
|
Not recommended
|
|
120
|
Heart failure—cardiac resynchronisation
|
May 2007
|
Partly recommended
|
|
121
|
Glioma (newly diagnosed and high grade)—carmustine implants and temozolomide
|
June 2007
|
Partly recommended
|
|
122
|
Ischaemic stroke (acute)—alteplase
|
June 2007
|
Recommended
|
|
123
|
Smoking cessation—varenicline
|
July 2007
|
Recommended
|
|
124
|
Non-small cell lung cancer—pemetrexed
|
August 2007
|
Not recommended
|
|
125
|
Psoriatic arthritis (moderate to severe)—adalimumab
|
August 2007
|
Partly recommended
|
|
126
|
Rheumatoid arthritis (refractory)—rituximab
|
August 2007
|
Partly recommended
|
|
127
|
Multiple sclerosis—natalizumab
|
August 2007
|
Recommended
|
|
128
|
Haemorrhoid—stapled haemorroidopexy
|
September 2007
|
Recommended
|
|
129
|
Velcade—multiple myeloma
|
October 2007
|
Recommended
|
|
130
|
Rheumatoid arthritis—adalimumab, etanercept and infliximab
|
October 2007
|
Partly recommended
|
|
131
|
Asthma (in children)—corticosteroids
|
November 2007
|
Partly recommended
|
|
132
|
Hypercholesterolemia—ezetimibe
|
November 2007
|
Partly recommended
|
|
133
|
Asthma (uncontrolled)—omalizumab
|
November 2007
|
Partly recommended
|
|
134
|
Psoriasis—infliximab
|
January 2008
|
Partly recommended
|
|
135
|
Mesothelioma—pemetrexed disodium
|
January 2008
|
Partly recommended
|
|
136
|
Structural neuroimaging in first-episode psychosis
|
February 2008
|
Not recommended
|
|
137
|
Lymphoma (follicular non-Hodgkin's)—rituximab
|
February 2008
|
Recommended
|
|
138
|
Asthma (in adults)—corticosteroids
|
March 2008
|
Partly recommended
|
|
139
|
Sleep apnoea—continuous positive airway pressure (CPAP)
|
March 2008
|
Partly recommended
|
|
140
|
Colitis (ulcerative)—infliximab
|
April 2008
|
Not recommended
|
|
141
|
Rheumatoid arthritis (refractory)—abatacept
|
April 2008
|
Not recommended
|
|
142
|
Anaemia (cancer-treatment induced)—erythropoietin (alpha and beta) and darbepoetin
|
May 2008
|
Partly recommended
|
|
143
|
Ankylosing spondylitis—adalimumab, etanercept and infliximab
|
May 2008
|
Partly recommended
|
|
144
|
Obesity—rimonabant
|
June 2008
|
Partly recommended
|
|
145
|
Head and neck cancer—cetuximab
|
June 2008
|
Partly recommended
|
|
146
|
Psoriasis—adalimumab
|
June 2008
|
Partly recommended
|
|
147
|
Breast cancer (advanced and metastatic)—bevacizumab
|
June 2008
|
Terminated
|
|
148
|
Lung cancer (non-small-cell)—bevacizumab
|
June 2008
|
Terminated
|
|
149
|
Glioma (recurrent)—carmustine implants
|
June 2008
|
Terminated
|
19 Nov 2008 : Column 527W
19 Nov 2008 : Column 528W
|
150
|
Colorectal cancer (metastatic)—cetuximab
|
June 2008
|
Terminated
|
|
151
|
Diabetes—insulin pump therapy
|
July 2008
|
Partly recommended
|
|
152
|
Coronary artery disease—drug-eluting stents
|
July 2008
|
Partly recommended
|
|
153
|
Hepatitis B—entecavir
|
August 2008
|
Recommended
|
|
154
|
Hepatitis B—telbivudine
|
August 2008
|
Not recommended
|
|
155
|
Macular degeneration (age-related)—ranibizumab and pegaptanib
|
August 2008
|
Partly recommended
|
|
156
|
Pregnancy (rhesus negative women)—routine anti-D (review)
|
August 2008
|
Partly recommended
|
|
157
|
Venous thromboembolism—dabigatran
|
September 2008
|
Recommended
|
|
158
|
Influenza (prophylaxis)—amantadine, oseltamivir and zanamivir
|
September 2008
|
Partly recommended
|
|
159
|
Pain (chronic neuropathic or ischaemic)—spinal cord stimulation
|
October 2008
|
Partly recommended
|
|
160
|
Osteoporosis—primary prevention
|
October 2008
|
Partly recommended
|
|
161
|
Osteoporosis—secondary prevention including strontium ranelate
|
October 2008
|
Partly recommended
|
